Shanghai Runda Medical Technology Co., Ltd. (603108.SS)
CNY 18.12
(3.13%)
CNY 18.12
(3.13%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.78 Billion CNY | -3.27% |
| 2022 | 1.63 Billion CNY | 19.06% |
| 2021 | 1.37 Billion CNY | 31.89% |
| 2020 | 1.04 Billion CNY | 5.14% |
| 2019 | 989.25 Million CNY | 22.39% |
| 2018 | 808.29 Million CNY | 26.36% |
| 2017 | 639.65 Million CNY | 75.32% |
| 2016 | 364.84 Million CNY | 37.26% |
| 2015 | 265.8 Million CNY | 22.62% |
| 2014 | 216.77 Million CNY | 26.52% |
| 2013 | 171.33 Million CNY | 19.96% |
| 2012 | 142.82 Million CNY | 0.41% |
| 2011 | 142.24 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 411.36 Million CNY | -13.11% |
| 2024 Q2 | 368.63 Million CNY | -10.39% |
| 2024 Q3 | 386.76 Million CNY | 18.43% |
| 2023 Q3 | 390.77 Million CNY | 2.6% |
| 2023 Q4 | 473.42 Million CNY | 21.15% |
| 2023 FY | 1.57 Billion CNY | -3.27% |
| 2023 Q1 | 356.04 Million CNY | -30.99% |
| 2023 Q2 | 380.88 Million CNY | 6.98% |
| 2022 Q2 | 341.02 Million CNY | -4.4% |
| 2022 Q1 | 356.72 Million CNY | -9.9% |
| 2022 FY | 1.63 Billion CNY | 19.06% |
| 2022 Q4 | 515.94 Million CNY | 22.98% |
| 2022 Q3 | 419.53 Million CNY | 23.02% |
| 2021 Q2 | 331.55 Million CNY | 12.91% |
| 2021 Q4 | 395.9 Million CNY | 12.88% |
| 2021 Q3 | 350.72 Million CNY | 5.78% |
| 2021 FY | 1.37 Billion CNY | 31.89% |
| 2021 Q1 | 293.62 Million CNY | -15.38% |
| 2020 Q3 | 270.2 Million CNY | 10.16% |
| 2020 FY | 1.04 Billion CNY | 5.14% |
| 2020 Q4 | 347 Million CNY | 28.42% |
| 2020 Q2 | 245.29 Million CNY | 39.4% |
| 2020 Q1 | 175.96 Million CNY | -46.1% |
| 2019 Q2 | 232.29 Million CNY | 16.12% |
| 2019 Q1 | 200.05 Million CNY | -15.76% |
| 2019 FY | 989.25 Million CNY | 22.39% |
| 2019 Q4 | 326.48 Million CNY | 44.82% |
| 2019 Q3 | 225.44 Million CNY | -2.95% |
| 2018 Q1 | 174.06 Million CNY | -10.18% |
| 2018 FY | 808.29 Million CNY | 26.36% |
| 2018 Q3 | 209.85 Million CNY | 14.69% |
| 2018 Q2 | 182.97 Million CNY | 5.12% |
| 2018 Q4 | 237.47 Million CNY | 13.16% |
| 2017 Q3 | 165.93 Million CNY | 17.87% |
| 2017 FY | 639.65 Million CNY | 75.32% |
| 2017 Q4 | 193.78 Million CNY | 16.79% |
| 2017 Q1 | 129.74 Million CNY | -1.12% |
| 2017 Q2 | 140.77 Million CNY | 8.5% |
| 2016 Q4 | 131.21 Million CNY | 40.35% |
| 2016 Q1 | 65.65 Million CNY | -19.06% |
| 2016 Q3 | 93.49 Million CNY | 33.93% |
| 2016 FY | 364.84 Million CNY | 37.26% |
| 2016 Q2 | 69.8 Million CNY | 6.33% |
| 2015 Q2 | 61.14 Million CNY | 14.08% |
| 2015 FY | 265.8 Million CNY | 22.62% |
| 2015 Q4 | 81.11 Million CNY | 20.22% |
| 2015 Q3 | 67.47 Million CNY | 10.35% |
| 2015 Q1 | 53.59 Million CNY | -19.4% |
| 2014 Q4 | 66.49 Million CNY | 25.12% |
| 2014 Q2 | 82.63 Million CNY | 95.41% |
| 2014 Q3 | 53.14 Million CNY | -35.69% |
| 2014 FY | 216.77 Million CNY | 26.52% |
| 2014 Q1 | 42.28 Million CNY | 0.0% |
| 2013 FY | 171.33 Million CNY | 19.96% |
| 2012 FY | 142.82 Million CNY | 0.41% |
| 2011 FY | 142.24 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 505.68 Million CNY | -252.949% |
| WuXi AppTec Co., Ltd. | 4.73 Billion CNY | 62.343% |
| Autobio Diagnostics Co., Ltd. | 1.52 Billion CNY | -16.987% |
| Thalys Medical Technology Group Inc. | 570.05 Million CNY | -213.095% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 2.35 Billion CNY | 24.222% |
| Chemclin Diagnostics Co., Ltd. | 169.33 Million CNY | -954.043% |